Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Sponsor: Kailera
Summary
The primary objective of the study is to determine the effects of KAI-9531 subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.
Official title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1800
Start Date
2025-12-18
Completion Date
2028-03-27
Last Updated
2026-03-02
Healthy Volunteers
No
Conditions
Interventions
KAI-9531
SC Injection
Placebo
SC Injection
Locations (22)
Kailera Clinical Site
Anniston, Alabama, United States
Kailera Clinical Site
Cullman, Alabama, United States
Kailera Clinical Site
Sun City, Arizona, United States
Kailera Clinical Site
Escondido, California, United States
Kailera Clinical Site
Toluca Lake, California, United States
Kailera Clinical Site
Aurora, Colorado, United States
Kailera Clinical Site
Bridgeport, Connecticut, United States
Kailera Clinical Site
Jupiter, Florida, United States
Kailera Clinical Site
Lilburn, Georgia, United States
Kailera Clinical Site
Springfield, Illinois, United States
Kailera Clinical Site
Columbia, Maryland, United States
Kailera Clinical Site
Las Vegas, Nevada, United States
Kailera Clinical Site
Rochester, New York, United States
Kailera Clinical Site
Morehead City, North Carolina, United States
Kailera Clinical Site
Chickasha, Oklahoma, United States
Kailera Clinical Site
Mauldin, South Carolina, United States
Kailera Clinical Site
Chattanooga, Tennessee, United States
Kailera Clinical Site
Amarillo, Texas, United States
Kailera Clinical Site
DeSoto, Texas, United States
Kailera Clinical Site
Tomball, Texas, United States
Kailera Clinical Site
Salt Lake City, Utah, United States
Kailera Clinical Site
Danville, Virginia, United States